Legend Biotech (LEGN) Debt Ratio (2021 - 2025)

Legend Biotech has reported Debt Ratio for 5 years, with the latest figure at 0.18 in Q4 2025.

• For the quarter ending Q4 2025, Debt Ratio rose 2.06% year-over-year to 0.18; the trailing twelve-month figure through Dec 2025 stood at 0.18 (up 2.06% YoY), and the FY2025 full-year result was 0.18, up 2.06% from the prior year.
• Debt Ratio for Q4 2025 stood at 0.18, up from 0.08 in the prior quarter.
• The five-year high for Debt Ratio was 0.22 in Q1 2023, with the low at 0.0 in Q2 2021.
• Historically, Debt Ratio has averaged 0.15 across 5 years, with a median of 0.16 in 2024.
• Annual changes were most pronounced in 2022 — Debt Ratio soared 82.19% — and 2025, when it plunged 51.19%.
• Legend Biotech's Debt Ratio stood at 0.11 in 2021, then surged by 82.19% to 0.2 in 2022, then slipped by 22.37% to 0.15 in 2023, then grew by 18.5% to 0.18 in 2024, then increased by 2.06% to 0.18 in 2025.
• The last three Debt Ratio figures came in at 0.18 (Q4 2025), 0.08 (Q3 2025), and 0.18 (Q2 2025), per Business Quant data.